Study Summary
This trial will explore if text messages can reduce heart disease risk in people living with HIV.
Eligible Conditions
- HIV/AIDS
- Atherosclerosis
- Cardiovascular Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 10 Secondary · Reporting Duration: 6 months
6 months
Blood sugar control
Body mass index
Cholesterol
Mediterranean diet
Number of cardiovascular risk factors controlled
Physical activity
Proportion of current smokers
Proportion of participants with controlled blood pressure
Proportion of patients on guideline-based therapy
Self-perceived cardiovascular risk
Systolic blood pressure
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control Arm
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment
260 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention Arm · No Placebo Group · N/A
Intervention Arm
Behavioral
Experimental Group · 1 Intervention: Digital Educational Messaging · Intervention Types: BehavioralControl ArmNoIntervention Group · 1 Intervention: Control Arm · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,616 Previous Clinical Trials
47,117,936 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,312 Previous Clinical Trials
11,758,066 Total Patients Enrolled
Megan McLaughlin, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment open for the trial at this time?
"Unfortunately, based on the information available at clinicaltrials.gov, this trial is not currently seeking participants; however, it was posted on January 1st 2023 and last updated November 29th 2022. Fortunately for those in search of a medical study to join, there are 1139 other trials recruiting patients presently." - Anonymous Online Contributor
Unverified Answer